ICL Group (NYSE: ICL) EVP discloses large vested and vesting options

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

ICL Group Ltd. executive Fahima Ilana, EVP and Chief People Officer, filed an initial statement of beneficial ownership showing significant stock option holdings in ICL Group.

She holds stock options over 649,180 ordinary shares with a $9.39 exercise price expiring on February 8, 2027, and options over 984,095 ordinary shares with a $5.87 exercise price expiring on April 4, 2029. According to the notes, one grant of stock options is fully vested and exercisable, while another grant vests in three equal annual installments from the April 4, 2024 grant date, with the options held by a trustee in her name.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Fahima Ilana

Role EVP, Chief People Officer

Type	Security	Shares	Price	Value
holding	Stock Options (Right to Buy)	--	--	--
holding	Stock Options (Right to Buy)	--	--	--

Holdings After Transaction: Stock Options (Right to Buy) — 649,180 shares (Direct)

Footnotes (1)

The stock options are fully vested and exercisable. The stock options vest in three equal annual installments from the April 4, 2024 grant date. Represents an exercise price of NIS 29.57, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026. The options are held by a Trustee in the name of the Reporting Person. Represents an exercise price of NIS 18.47, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

Key Figures

Underlying shares (first grant): 649,180 shares Exercise price (first grant): $9.39 per share Expiration date (first grant): February 8, 2027 +3 more

6 metrics

Underlying shares (first grant) 649,180 shares Stock options on ordinary shares

Exercise price (first grant) $9.39 per share Converted from NIS 29.57 using Bank of Israel rate

Expiration date (first grant) February 8, 2027 Stock options (right to buy) on ordinary shares

Underlying shares (second grant) 984,095 shares Stock options on ordinary shares

Exercise price (second grant) $5.87 per share Converted from NIS 18.47 using Bank of Israel rate

Expiration date (second grant) April 4, 2029 Stock options (right to buy) on ordinary shares

Key Terms

Stock Options (Right to Buy), Ordinary Shares, exercise price, Bank of Israel representative exchange rate, +1 more

5 terms

Stock Options (Right to Buy) financial

"security_title: Stock Options (Right to Buy)"

Ordinary Shares financial

"underlying_security_title: Ordinary Shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

exercise price financial

"Represents an exercise price of NIS 29.57, converted to U.S. dollars"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Bank of Israel representative exchange rate financial

"using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149"

Trustee financial

"The options are held by a Trustee in the name of the Reporting Person."

A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.

Understanding Insider Trading Forms →

03/30/2026 - 06:33 PM

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Fahima Ilana

(Last)

(First)

(Middle)

C/O ICL GROUP LTD.

MILLENNIUM TOWER, 23 ARENHA ST.

(Street)

TEL AVIV

6120201

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ICL Group Ltd. [ ICL ]

3a. Foreign Trading Symbol
[ICL]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Chief People Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options (Right to Buy)	⁽¹⁾	02/08/2027	Ordinary Shares	649,180	$9.39⁽³⁾	D⁽⁴⁾
Stock Options (Right to Buy)	⁽²⁾	04/04/2029	Ordinary Shares	984,095	$5.87⁽⁵⁾	D⁽⁴⁾

Explanation of Responses:

1. The stock options are fully vested and exercisable.

2. The stock options vest in three equal annual installments from the April 4, 2024 grant date.

3. Represents an exercise price of NIS 29.57, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

4. The options are held by a Trustee in the name of the Reporting Person.

5. Represents an exercise price of NIS 18.47, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

	/s/ Fahima Ilana	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What does ICL (ICL) executive Fahima Ilana report in this Form 3?

Fahima Ilana reports her beneficial ownership of ICL stock options. The filing lists two option grants over hundreds of thousands of ordinary shares, disclosing exercise prices, expiration dates, and vesting terms, giving investors visibility into her equity-based compensation exposure.

How many ICL (ICL) shares are covered by Fahima Ilana’s stock options?

The filing lists options over 649,180 underlying ordinary shares in one grant and 984,095 underlying ordinary shares in another. These figures represent the number of ICL ordinary shares that could be acquired upon exercising the respective option grants.

What are the exercise prices of the ICL (ICL) stock options reported?

One option grant carries an exercise price of $9.39 per share and the other $5.87 per share. These U.S. dollar amounts reflect conversions from New Israeli Shekel exercise prices using a specified Bank of Israel representative exchange rate.

When do Fahima Ilana’s reported ICL (ICL) stock options expire?

The option grant with a $9.39 exercise price expires on February 8, 2027. The grant with a $5.87 exercise price expires on April 4, 2029. These expiration dates define the latest dates on which the options may be exercised under their current terms.

How do the ICL (ICL) stock options reported by Fahima Ilana vest?

One set of stock options is fully vested and exercisable, meaning all underlying shares are currently available to exercise. Another grant vests in three equal annual installments starting from the April 4, 2024 grant date, spreading vesting over multiple years.

Who holds the ICL (ICL) options reported by Fahima Ilana?

The filing notes that the options are held by a trustee in the name of the reporting person. This means a trustee formally holds the options on her behalf while she remains the beneficial owner of the underlying economic interests.